VTechWorks staff will be away for the winter holidays starting Tuesday, December 24, 2024, through Wednesday, January 1, 2025, and will not be replying to requests during this time. Thank you for your patience, and happy holidays!
 

Potential Impacts of Pharmaceutical Uses of Transgenic Tobacco: The Case of Human Serum Albumin and Gaucher's Disease Treatment

Simple item page
dc.contributor.authorKostandini, Gentianen
dc.contributor.committeechairMills, Bradford F.en
dc.contributor.committeecochairNorton, George W.en
dc.contributor.committeememberReaves, Dixie Wattsen
dc.contributor.departmentAgricultural and Applied Economicsen
dc.date.accessioned2011-08-06T16:06:25Zen
dc.date.adate2004-09-16en
dc.date.available2011-08-06T16:06:25Zen
dc.date.issued2004-07-15en
dc.date.rdate2004-09-16en
dc.date.sdate2004-09-15en
dc.description.abstractThis thesis examines the size and distribution of benefits from the use of transgenic tobacco as a production vehicle for pharmaceutical proteins. Ex-ante welfare benefits are estimated for the introduction of two biotech innovations. In both cases economic surplus model with imperfect competition is employed to assess the size and distribution of benefits from these alternative uses of tobacco. An introductory chapter presents an overview of the topic followed by chapters 2 and 3 which contain the two case studies. The first paper (chapter 2) examines the case of Human Serum Albumin production from transgenic tobacco. The second paper (chapter 3) examines the case of Glucocerebrosidase Enzyme from transgenic tobacco. Results demonstrate that new products from bio-pharming applications stand to generate significant social benefits. The introduction of Human Serum Albumin generates average annual gains of $46 million and the introduction of Glucocerebrosidase Enzyme generates average annual gains of $500 to $600 million.en
dc.description.degreeMaster of Scienceen
dc.format.mediumETDen
dc.identifier.otheretd-09152004-154300en
dc.identifier.sourceurlhttp://scholar.lib.vt.edu/theses/available/etd-09152004-154300en
dc.identifier.urihttp://hdl.handle.net/10919/10119en
dc.publisherVirginia Techen
dc.relation.haspartThesisAbstractandTableofContents.pdfen
dc.relation.haspartThesisChapter1and2and3.pdfen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectPharmaceutical uses of tobaccoen
dc.subjecteconomic surplusen
dc.subjectimperfect competitionen
dc.titlePotential Impacts of Pharmaceutical Uses of Transgenic Tobacco: The Case of Human Serum Albumin and Gaucher's Disease Treatmenten
dc.typeThesisen
thesis.degree.disciplineAgricultural and Applied Economicsen
thesis.degree.grantorVirginia Polytechnic Institute and State Universityen
thesis.degree.levelmastersen
thesis.degree.nameMaster of Scienceen

Files

Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
ThesisAbstractandTableofContents.pdf
Size:
67.75 KB
Format:
Adobe Portable Document Format
Download
Thumbnail Image
Name:
ThesisChapter1and2and3.pdf
Size:
421.58 KB
Format:
Adobe Portable Document Format
Download

Collections

Masters Theses